COMPLICATIONS OF BONE MARROW TRANSPLANT side effect
What is COMPLICATIONS OF BONE MARROW TRANSPLANT ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
COMPLICATIONS OF BONE MARROW TRANSPLANT and Recently Reported Side Effects
COMPLICATIONS OF BONE MARROW TRANSPLANT and 15 most Active Side Effect polls
COMPLICATIONS OF BONE MARROW TRANSPLANT and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with COMPLICATIONS OF BONE MARROW TRANSPLANT
AMMONUL CYCLOSPORINE FLUDARA FLUDARABINE FORTEO IMATINIB MATCHED PROGRAF RITUXAN VELCADE VIDAZAPrograf Side Effects Report #5679942-5
Physician from JAPAN reported PROGRAF problem on Mar 07, 2008. Male patient, 65 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, cytomegalovirus antigen positive, pulmonary alveolar haemorrhage, . PROGRAF dosage: unknown. Patient recovered.
Forteo Side Effects Report #5634397-1
FORTEO problem was reported by a Consumer or non-health professional from CANADA on Feb 13, 2008. Female patient, 60 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, pneumonia, . FORTEO dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, LOSEC I, DOMPERIDONE, SEPTRA, CALCIUM, VITAMIN D. Patient was hospitalized. Patient recovered.
Fludara Side Effects Report #5635026-3
Consumer or non-health professional from GERMANY reported FLUDARA problem on Feb 07, 2008. Female patient was diagnosed with immunosuppression and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARA dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with AMSACRINE, CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE, ANTITHYMOCYTE GLOBULIN, ANTITHYMOCYTE GLOBULIN, IMMUNOSUPPRESSANTS. Patient died.
Fludara Side Effects Report #5635029-9
FLUDARA problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2008. Female patient was diagnosed with immunosuppression and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARA dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with AMSACRINE, CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE, ANTITHYMOCYTE GLOBULIN, ANTITHYMOCYTE GLOBULIN, IMMUNOSUPPRESSANTS. Patient died.
Fludarabine Side Effects Report #5635030-5
Consumer or non-health professional from FRANCE reported FLUDARABINE problem on Feb 07, 2008. Female patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARABINE dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with TREOSULFAN, ANTITHYMOCYTE GLOBULIN. Patient died.
Fludara Side Effects Report #5639537-6
FLUDARA problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2008. Female patient was diagnosed with immunosuppression and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARA dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with AMSACRINE, CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE, ANTITHYMOCYTE GLOBULIN, ANTITHYMOCYTE GLOBULIN, IMMUNOSUPPRESSANTS. Patient died.
Fludarabine Side Effects Report #5639538-8
Consumer or non-health professional from FRANCE reported FLUDARABINE problem on Feb 07, 2008. Female patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARABINE dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with TREOSULFAN, ANTITHYMOCYTE GLOBULIN. Patient died.
Fludara Side Effects Report #5639565-0
FLUDARA problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2008. Female patient was diagnosed with immunosuppression and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARA dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with AMSACRINE, CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE, ANTITHYMOCYTE GLOBULIN, ANTITHYMOCYTE GLOBULIN, IMMUNOSUPPRESSANTS. Patient died.
Rituxan Side Effects Report #5445046-X
Health Professional from CANADA reported RITUXAN problem on Aug 29, 2007. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . RITUXAN dosage: 800 MG, UNK. Patient died.
Cyclosporine Side Effects Report #5339236-4
CYCLOSPORINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Male patient, 49 years of age, was diagnosed with angioimmunoblastic t-cell lymphoma and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, lymphoproliferative disorder, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISONE. Patient died.
Cyclosporine Side Effects Report #5339237-6
Consumer or non-health professional from UNITED STATES reported CYCLOSPORINE problem on May 21, 2007. Female patient, 55 years of age, was diagnosed with angioimmunoblastic t-cell lymphoma and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . CYCLOSPORINE dosage: unknown. Patient died.
Matched Side Effects Report #5254774-0
MATCHED SIBLING BONE MARROW problem was reported by a Health Professional from UNITED STATES on Mar 01, 2007. Female patient, child 11 years of age, weighting 70.77 lb, was treated with MATCHED SIBLING BONE MARROW. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, staphylococcal infection, . MATCHED SIBLING BONE MARROW dosage: unknown. Patient recovered.
Prograf Side Effects Report #5613361-2
Physician from JAPAN reported PROGRAF problem on Jan 10, 2008. Male patient, 41 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: angiopathy, complications of bone marrow transplant, graft versus host disease, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE, METHYLPREDNISOLONE. Patient died.
Velcade Side Effects Report #5572380-5
VELCADE problem was reported by a Physician from SPAIN on Dec 12, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, complications of bone marrow transplant, . VELCADE dosage: 1.30 MG/M2,. Patient died.
Vidaza Side Effects Report #5762002-2
Physician from FRANCE reported VIDAZA problem on May 20, 2008. Male patient, 50 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, complications of bone marrow transplant, cytolytic hepatitis, renal failure, . VIDAZA dosage: 75 MG/M2, DAILY, SUBCUTANEOUS. During the same period patient was treated with ROVAMYCINE, VALACYCLOVIR, CORTICOSTEROIDS, GRANOCYTE, AUGMENTIN, AMOXICILLIN. Patient recovered.
Cyclosporine Side Effects Report #5284264-0
CYCLOSPORINE problem was reported by a Health Professional from UNITED STATES on Mar 28, 2007. Male patient, 49 years of age, was diagnosed with angioimmunoblastic t-cell lymphoma recurrent and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count increased, complications of bone marrow transplant, leukocytosis, lymphoproliferative disorder, malignant neoplasm progression, pharyngitis, plasmablast count increased, stem cell transplant, . CYCLOSPORINE dosage: unknown. Patient died.
Prograf Side Effects Report #5313440-3
Physician from JAPAN reported PROGRAF problem on Apr 13, 2007. Male patient, 54 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, complications of bone marrow transplant, diabetic hyperglycaemic coma, encephalitis herpes, encephalopathy, histiocytosis haematophagic, human herpesvirus 6 infection, hyperkinesia, memory impairment, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE, CORTICOSTEROIDS, ACYCLOVIR, GANCICLOVIR, FOSCARNET, IMMUNE GLOBULIN INTRAVENOUS. Patient died.
Ammonul Side Effects Report #5663683-4
AMMONUL problem was reported by a Physician from FRANCE on Feb 25, 2008. Female patient, 19 years of age, was diagnosed with hyperammonaemia, prophylaxis and was treated with AMMONUL. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, coma, complications of bone marrow transplant, dialysis, epilepsy, haemorrhage, intra-abdominal haematoma, respiratory depression, . AMMONUL dosage: unknown. During the same period patient was treated with POSCONAZOLE, NEXIUM, AMMONAPS, TIENAM, ORGARAN, LEVOCARNIL, ARGININE, MORPHINE. Patient died on 01/24/2008.
Ammonul Side Effects Report #5622930-5
Physician from FRANCE reported AMMONUL problem on Jan 22, 2008. Female patient, 19 years of age, weighting 121.3 lb, was diagnosed with hyperammonaemia, prophylaxis and was treated with AMMONUL. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, coma, complications of bone marrow transplant, epilepsy, gastric disorder, haematoma, haemorrhage, hyperammonaemia, . AMMONUL dosage: unknown. During the same period patient was treated with POSOCONAZOLE, NEXIUM, AMMONAPS, TIENAM, ORGARAN, LEVOCARNIL, ARGININE, MORPHINE. Patient died on 01/24/2008.
Imatinib Side Effects Report #5391966-4
IMATINIB MESYLATE problem was reported by a Health Professional from UNITED STATES on July 13, 2007. Female patient, 42 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chromosome analysis abnormal, complications of bone marrow transplant, . IMATINIB MESYLATE dosage: 400 MG/D. During the same period patient was treated with IMATINIB MESYLATE. Patient died.
Imatinib Side Effects Report #5391966-4
Health Professional from UNITED STATES reported IMATINIB MESYLATE problem on July 13, 2007. Female patient, 42 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chromosome analysis abnormal, complications of bone marrow transplant, . IMATINIB MESYLATE dosage: 400 MG/D. During the same period patient was treated with IMATINIB MESYLATE. Patient died.
Prograf Side Effects Report #5376224-6
PROGRAF problem was reported by a Physician from JAPAN on June 18, 2007. Male patient, weighting 11.68 lb, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: aspergillosis, bronchitis moraxella, complications of bone marrow transplant, fungal endocarditis, graft versus host disease, infection in an immunocompromised host, . PROGRAF dosage: 0.1 MG, BID, ORAL. During the same period patient was treated with PREDNISOLONE, METHOTREXATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TEICOPLANIN, MEROPENEM, FLUCONAZOLE, FUNGUARD. Patient was hospitalized. Patient recovered.